Skip to main content
Erschienen in: Acta Neuropathologica 4/2007

01.04.2007 | Original Paper

Diagnostic value of ultrastructural nerve examination in Charcot-Marie-Tooth disease: two CMT 1B cases with pseudo-recessive inheritance

verfasst von: Jean-Michel Vallat, Laurent Magy, Emmeline Lagrange, Franck Sturtz, Corinne Magdelaine, Djamel Grid, Mériem Tazir

Erschienen in: Acta Neuropathologica | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

We report two sporadic patients of CMT disease in different consanguineous families. The electrophysiological examination led to the diagnosis of a severe demyelinating neuropathy. The nerve biopsies exhibited numerous outfoldings of the myelin sheaths and onion-bulb proliferations. The consanguinity and the histological findings pointed to a diagnosis of CMT 4B. However, the detection of abnormal and regular widenings between the major dense lines of the myelin lamellae by electron microscopy led us to search for a P0 gene mutation. Two heterozygous mutations of this gene were identified: S63F and N131Y. Different aspects of uncompacted myelin lamellae have been described in some cases of P0 mutations and a few now appear to be quite specific to it. More than 30 genes are implicated in CMT and as mutation search is time- and money-consuming, we believe that in some selected patients ultrastructural examination of nerves, among other criteria, helps orientate the molecular diagnosis of CMT.
Literatur
1.
Zurück zum Zitat Gabreëls-Festen AAWM, Hoogendijk JE, Meijerink PHS, Gabreëls FJM, Bolhuis PA, van Beersum S, Kulkens T, Nelis E, Jennekens FGI, de Visser M, van Engelen BGM, van Broeckhoven C, Mariman ECM (1996) Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 47:461–765 Gabreëls-Festen AAWM, Hoogendijk JE, Meijerink PHS, Gabreëls FJM, Bolhuis PA, van Beersum S, Kulkens T, Nelis E, Jennekens FGI, de Visser M, van Engelen BGM, van Broeckhoven C, Mariman ECM (1996) Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 47:461–765
2.
Zurück zum Zitat Hasse B, Bosse F, Hanenberg H, Muller HW (2004) Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions. Mol Cell Neurosci 27:370–378PubMedCrossRef Hasse B, Bosse F, Hanenberg H, Muller HW (2004) Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions. Mol Cell Neurosci 27:370–378PubMedCrossRef
3.
Zurück zum Zitat Kochanski A, Drac H, Jedrzejowska H, Hausmanowa-Petrusewicz I (2003) Focally folded myelin in Charcot-Marie-Tooth type 1B disease is associated with Asn131Lys mutation in myelin protein zero gene : short report. Eur J Neurol10:547–549PubMedCrossRef Kochanski A, Drac H, Jedrzejowska H, Hausmanowa-Petrusewicz I (2003) Focally folded myelin in Charcot-Marie-Tooth type 1B disease is associated with Asn131Lys mutation in myelin protein zero gene : short report. Eur J Neurol10:547–549PubMedCrossRef
4.
Zurück zum Zitat Komiyama A, Ohnishi A, Izawa K, Yamamori S, Ohashi H, Hasegawa O (1997) De novo mutation (Arg98 →Cys) of the myelin P0 gene and uncompaction of the major dense line of the myelin sheath in a severe variant of Charcot-Marie-Tooth disease type 1B. J Neurol Sci 149:103–109PubMedCrossRef Komiyama A, Ohnishi A, Izawa K, Yamamori S, Ohashi H, Hasegawa O (1997) De novo mutation (Arg98 →Cys) of the myelin P0 gene and uncompaction of the major dense line of the myelin sheath in a severe variant of Charcot-Marie-Tooth disease type 1B. J Neurol Sci 149:103–109PubMedCrossRef
5.
Zurück zum Zitat Lagueny A, Latour P, Vital A, Le Masson G, Rouanet M, Ferrer X, Vital C, Vandenberghe A (2001) Mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene. J Neurol Neurosurg Psy 70:232–235CrossRef Lagueny A, Latour P, Vital A, Le Masson G, Rouanet M, Ferrer X, Vital C, Vandenberghe A (2001) Mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene. J Neurol Neurosurg Psy 70:232–235CrossRef
6.
Zurück zum Zitat Lagueny A, Latour P, Vital A, Rajabally Y, Le Masson G, Ferrer X, Bernard I, Julien J, Vital C, Vandenberghe A (1999) Peripheral myelin modification in CMT 1B correlates with MPZ gene mutations. Neuromusc Dis 9:361–367PubMedCrossRef Lagueny A, Latour P, Vital A, Rajabally Y, Le Masson G, Ferrer X, Bernard I, Julien J, Vital C, Vandenberghe A (1999) Peripheral myelin modification in CMT 1B correlates with MPZ gene mutations. Neuromusc Dis 9:361–367PubMedCrossRef
7.
Zurück zum Zitat Ohnishi A, Yamamoto T, Yamamori S, Sudo K, Fukushima Y, Ikeda M (1999) Myelinated fibers in Charcot-Marie-Tooth disease type 1B with Arg98His mutation of P0 protein. J Neurol Sci 171:97–109PubMedCrossRef Ohnishi A, Yamamoto T, Yamamori S, Sudo K, Fukushima Y, Ikeda M (1999) Myelinated fibers in Charcot-Marie-Tooth disease type 1B with Arg98His mutation of P0 protein. J Neurol Sci 171:97–109PubMedCrossRef
8.
Zurück zum Zitat Vallat JM, Tazir M, Magdelaine C, Sturtz F, Grid D (2005b) Autosomal-recessive Charcot-Marie-Tooth diseases. J Neuropathol Exp Neurol 64:363–370 Vallat JM, Tazir M, Magdelaine C, Sturtz F, Grid D (2005b) Autosomal-recessive Charcot-Marie-Tooth diseases. J Neuropathol Exp Neurol 64:363–370
9.
Zurück zum Zitat Xu W, Manichella D, Jiang H, Vallat JM, Lilien J, Baron P, Scarlato G, Kamholz J, Shy ME (2000) Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis. J Neurosci Res 60:714–724PubMedCrossRef Xu W, Manichella D, Jiang H, Vallat JM, Lilien J, Baron P, Scarlato G, Kamholz J, Shy ME (2000) Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis. J Neurosci Res 60:714–724PubMedCrossRef
10.
Zurück zum Zitat Planté-Bordeneuve V, Guiochon-Mantel A, Lacroix C, Lapresle J, Said G (1999) The Roussy-Lévy family: from the original description to the gene. Ann Neurol 46:770–773PubMedCrossRef Planté-Bordeneuve V, Guiochon-Mantel A, Lacroix C, Lapresle J, Said G (1999) The Roussy-Lévy family: from the original description to the gene. Ann Neurol 46:770–773PubMedCrossRef
11.
Zurück zum Zitat Blanquet-Grossard F, Pham-Dinh D, Dautigny A, Latour P, Bonnebouche C, Corbillon E, Chazot G, Vandenberghe A (1995) Charcot-Marie-Tooth 1B neuropathy: third mutation of serine 63 codon in the major peripheral myelin glycoprotein P0 gene. Clin Genet 48:281–283PubMedCrossRef Blanquet-Grossard F, Pham-Dinh D, Dautigny A, Latour P, Bonnebouche C, Corbillon E, Chazot G, Vandenberghe A (1995) Charcot-Marie-Tooth 1B neuropathy: third mutation of serine 63 codon in the major peripheral myelin glycoprotein P0 gene. Clin Genet 48:281–283PubMedCrossRef
12.
Zurück zum Zitat Lee YC, Soong BW, Lin KP, Lee HY, Wu ZA, Kao KP (2004) Myelin protein zero gene mutations in Taiwanese patients with Charcot-Marie-Tooth disease type 1. J Neurol Sci 219:95–100PubMedCrossRef Lee YC, Soong BW, Lin KP, Lee HY, Wu ZA, Kao KP (2004) Myelin protein zero gene mutations in Taiwanese patients with Charcot-Marie-Tooth disease type 1. J Neurol Sci 219:95–100PubMedCrossRef
13.
Zurück zum Zitat Mostacciuolo ML, Righetti E, Zortea M, Bosello V, Schiavon F, Vallo L, Merlini L, Siciliano G, Fabrizi GM, Rizzuto N, Milani M, Baratta S, Taroni F (2001) Charcot-Marie-Tooth disease type 1 and related demyelinating neuropathies : mutation analysis in a large cohort of Italian families. Hum Mutat 18:32–41PubMedCrossRef Mostacciuolo ML, Righetti E, Zortea M, Bosello V, Schiavon F, Vallo L, Merlini L, Siciliano G, Fabrizi GM, Rizzuto N, Milani M, Baratta S, Taroni F (2001) Charcot-Marie-Tooth disease type 1 and related demyelinating neuropathies : mutation analysis in a large cohort of Italian families. Hum Mutat 18:32–41PubMedCrossRef
14.
Zurück zum Zitat Leal A, Berghoff C, Berghoff M, Del Valle G, Contreras C, Montoya O, Hernández E, Barrantes R, Schlötzer-Schrehardt U, Neundörfer B, Reis A, Rautenstrauss B, Heuss D (2003) Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family. Neurogenetics 4:191–197PubMedCrossRef Leal A, Berghoff C, Berghoff M, Del Valle G, Contreras C, Montoya O, Hernández E, Barrantes R, Schlötzer-Schrehardt U, Neundörfer B, Reis A, Rautenstrauss B, Heuss D (2003) Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family. Neurogenetics 4:191–197PubMedCrossRef
15.
Zurück zum Zitat D’Urso D, Brophy PJ, Staugaitis SM, Gillespie CS, Frey AB, Stempak JG, Colman DR (1990) Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 4:449–460PubMedCrossRef D’Urso D, Brophy PJ, Staugaitis SM, Gillespie CS, Frey AB, Stempak JG, Colman DR (1990) Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 4:449–460PubMedCrossRef
16.
Zurück zum Zitat Fabrizi GM, Cavallaro T, Taioli F, Orrico D, Morbin M, Dimonati A, Rizzuto N (1999) Myelin uncompaction in Charcot-Marie-Tooth neuropathy type 1A with a point mutation of peripheral myelin protein-22. Neurology 53:846–851PubMed Fabrizi GM, Cavallaro T, Taioli F, Orrico D, Morbin M, Dimonati A, Rizzuto N (1999) Myelin uncompaction in Charcot-Marie-Tooth neuropathy type 1A with a point mutation of peripheral myelin protein-22. Neurology 53:846–851PubMed
17.
Zurück zum Zitat Shapiro L, Doyle JP, Hensley P, Colman DR, Hendrickson WA (1996) Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17:435–449PubMedCrossRef Shapiro L, Doyle JP, Hensley P, Colman DR, Hendrickson WA (1996) Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17:435–449PubMedCrossRef
18.
Zurück zum Zitat Ding Y, Brunden KR (1994) The cytoplasmic domain of myelin glycoprotein P0 interacts with negatively charged phospholipid bilayers. J Biol Chem 269:10764–10770PubMed Ding Y, Brunden KR (1994) The cytoplasmic domain of myelin glycoprotein P0 interacts with negatively charged phospholipid bilayers. J Biol Chem 269:10764–10770PubMed
19.
Zurück zum Zitat Wong MH, Filbin MT (1996) Dominant-negative effect on adhesion by myelin P0 protein truncated in its cytoplasmic domain. J Cell Biol 134:1531–1541PubMedCrossRef Wong MH, Filbin MT (1996) Dominant-negative effect on adhesion by myelin P0 protein truncated in its cytoplasmic domain. J Cell Biol 134:1531–1541PubMedCrossRef
20.
Zurück zum Zitat Xu W, Shy M, Kamholz J, Elferinck L, Xu G, Lilien J, Balsamo J (2001) Mutations in the cytoplasmic domain of the myelin P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination. J Cell Biol 155:439–446PubMedCrossRef Xu W, Shy M, Kamholz J, Elferinck L, Xu G, Lilien J, Balsamo J (2001) Mutations in the cytoplasmic domain of the myelin P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination. J Cell Biol 155:439–446PubMedCrossRef
21.
Zurück zum Zitat Ohnishi A, Hirano A (1981) Uncompacted myelin lamellae in dysglobulinemic neuropathy. J Neurol Sci 51:131–140PubMedCrossRef Ohnishi A, Hirano A (1981) Uncompacted myelin lamellae in dysglobulinemic neuropathy. J Neurol Sci 51:131–140PubMedCrossRef
22.
Zurück zum Zitat Warner LE, Hilz MJ, Appel SH, Killian JM, Kolodry EH, Karpati G, Carpenter S, Watters GV, Wheeler C, Witt D, Bodell A, Nelis E, Van Broeckhoven C, Lupski JR (1996) Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and Congenital Hypomyelination. Neuron 17:451–460PubMedCrossRef Warner LE, Hilz MJ, Appel SH, Killian JM, Kolodry EH, Karpati G, Carpenter S, Watters GV, Wheeler C, Witt D, Bodell A, Nelis E, Van Broeckhoven C, Lupski JR (1996) Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and Congenital Hypomyelination. Neuron 17:451–460PubMedCrossRef
23.
Zurück zum Zitat Vital C, Vital A, Bouillot S, Favereaux A, Lagueny A, Ferrer X, Brechenmacher C, Petry KG (2003) Uncompacted myelin lamellae in peripheral nerve biopsy. Ultrastructur Pathol 27:1–5CrossRef Vital C, Vital A, Bouillot S, Favereaux A, Lagueny A, Ferrer X, Brechenmacher C, Petry KG (2003) Uncompacted myelin lamellae in peripheral nerve biopsy. Ultrastructur Pathol 27:1–5CrossRef
24.
Zurück zum Zitat Vallat JM, Magy L, Sindou P, Magdelaine C, Cros D (2005a) IgG neuropathy: an immunoelectron microscopic study. J Neuropathol Exp Neurol 64:386–390 Vallat JM, Magy L, Sindou P, Magdelaine C, Cros D (2005a) IgG neuropathy: an immunoelectron microscopic study. J Neuropathol Exp Neurol 64:386–390
25.
Zurück zum Zitat Yoshikawa H, Dyck PJ (1991) Uncompacted inner myelin lamellae in inherited tendency to pressure palsies. Neuropathol Exp Neurol 50:649–657CrossRef Yoshikawa H, Dyck PJ (1991) Uncompacted inner myelin lamellae in inherited tendency to pressure palsies. Neuropathol Exp Neurol 50:649–657CrossRef
26.
Zurück zum Zitat Li J, Bai Y, Ghandour K, Qin P, Grandis M, Trostinskaia A, Ianakova E, Wu X, Schenone A, Vallat JM, Kupsky WJ, Hatfield J, Shy ME (2005) Skin biopsies in myelin-related neuropathies : bringing molecular pathology to the bedside. Brain 128:1168–1177PubMedCrossRef Li J, Bai Y, Ghandour K, Qin P, Grandis M, Trostinskaia A, Ianakova E, Wu X, Schenone A, Vallat JM, Kupsky WJ, Hatfield J, Shy ME (2005) Skin biopsies in myelin-related neuropathies : bringing molecular pathology to the bedside. Brain 128:1168–1177PubMedCrossRef
27.
Zurück zum Zitat Meijerink PHS, Hoogendijk JE, Gabreëls-Festen AAWM, Zorn I, Veldman H, Baas F, De Visser M, Bolhuis PA (1996) Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies. Ann Neurol 40:672–675PubMedCrossRef Meijerink PHS, Hoogendijk JE, Gabreëls-Festen AAWM, Zorn I, Veldman H, Baas F, De Visser M, Bolhuis PA (1996) Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies. Ann Neurol 40:672–675PubMedCrossRef
28.
Zurück zum Zitat Vallat JM, Tabaraud F, Sindou P, Preux PM, Vandenberghe A, Steck A (2000) Myelin widenings and MGUS-IgA: an immunoelectron microscopic study. Ann Neurol 47:808–811PubMedCrossRef Vallat JM, Tabaraud F, Sindou P, Preux PM, Vandenberghe A, Steck A (2000) Myelin widenings and MGUS-IgA: an immunoelectron microscopic study. Ann Neurol 47:808–811PubMedCrossRef
Metadaten
Titel
Diagnostic value of ultrastructural nerve examination in Charcot-Marie-Tooth disease: two CMT 1B cases with pseudo-recessive inheritance
verfasst von
Jean-Michel Vallat
Laurent Magy
Emmeline Lagrange
Franck Sturtz
Corinne Magdelaine
Djamel Grid
Mériem Tazir
Publikationsdatum
01.04.2007
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 4/2007
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-007-0196-7

Weitere Artikel der Ausgabe 4/2007

Acta Neuropathologica 4/2007 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.